Literature DB >> 7459535

The pattern of lymph node metastases in intra-oral squamous cell carcinoma.

D T Sharpe.   

Abstract

Histological study of all radical neck dissection specimens from 98 patients with clinically operable intra-oral squamous cell carcinoma has been carried out since 1973 to establish not only the presence of positive nodes but their site in the neck. All cases treated primarily by other methods such as radiotherapy or chemotherapy were excluded. Positive lymph nodes, found in 73 specimens, were grouped according to the site of the primary lesion. In no patient were nodal metastases found in the posterior triangle or in the submental region. No tumour deposits were found in the salivary glands nor were any found either in or superficial to the sternomastoid muscle. Obviously several factors must be taken into account in deciding the place of "functional" as distinct from radical neck dissection in the treatment of intra-oral malignancy, but the findings in this survey provide evidence in favour of the simpler less radical approach.

Entities:  

Mesh:

Year:  1981        PMID: 7459535     DOI: 10.1016/0007-1226(81)90110-7

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  3 in total

1.  Is Site-Specific Assessment of Neck Nodes Relevant for Neck Dissection.

Authors:  Vinay Singh Yadav; Venkatesh Srinivasa Rao Anehosur; Sahana Adirajaiah; Keerthana Krishnamurthy
Journal:  J Maxillofac Oral Surg       Date:  2021-02-27

2.  What is optimum neck dissection for T3/4 buccal-gingival cancers?

Authors:  S A Pradhan; A K D'Cruz; R I Gulla
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

3.  How is neck dissection performed in Oral and Maxillofacial Surgery? Results of a representative nationwide survey among university and non-university hospitals in Germany.

Authors:  Andreas Pabst; Daniel G E Thiem; Elisabeth Goetze; Alexander K Bartella; Michael T Neuhaus; Jürgen Hoffmann; Alexander-N Zeller
Journal:  Clin Oral Investig       Date:  2021-03-29       Impact factor: 3.573

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.